To avoid short­age of Mer­ck­'s di­a­betes drug, FDA al­lows high­er im­pu­ri­ty lev­els tem­porar­i­ly

The FDA said Tues­day that it re­cent­ly be­came aware of a ni­trosamine im­pu­ri­ty, Ni­troso-STG-19 or NTTP, in cer­tain sam­ples of Mer­ck’s type 2 di­a­betes drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.